As such, the reduced levels of stromal SFRP1 and SFRP2 in DCIS and IDC may facilitate WNT signaling and promote breast cancer growth, survival, invasion, or stem cell activity. Here, SFRP2 is linked to ductal breast carcinoma in situ.